In addition, it was demonstrated that tumor cells released the NKG2D ligands, MICA and MICB, in a soluble form by proteolytic shedding from the tumor cell surface by metalloproteases [29] and protected tumor cells from cytolysis if they were NKG2DL-positive. The gene discussed is MICA; the disease is neoplasm.